Patents by Inventor Andrea Osterlehner

Andrea Osterlehner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230129340
    Abstract: Herein are provided a method for producing a multispecific antibody comprising the steps of providing a mammalian cell expressing the antibody, transfecting said mammalian cell with an expression vector comprising an expression cassette encoding a polypeptide of the antibody that has a domain crossover, cultivating the transfected cell and recovering the antibody from the cell or the cultivation medium and thereby producing the multispecific antibody.
    Type: Application
    Filed: May 25, 2022
    Publication date: April 27, 2023
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Stefan SEEBER, Ulrich GOEPFERT, Andrea OSTERLEHNER, Hubert KETTENBERGER, Wolfgang PAUL
  • Publication number: 20200216553
    Abstract: Herein are provided a method for producing a multispecific antibody comprising the steps of providing a mammalian cell expressing the antibody, transfecting said mammalian cell with an expression vector comprising an expression cassette encoding a polypeptide of the antibody that has a domain crossover, cultivating the transfected cell and recovering the antibody from the cell or the cultivation medium and thereby producing the multispecific antibody.
    Type: Application
    Filed: September 4, 2019
    Publication date: July 9, 2020
    Applicant: Hoffmann-La Roche Inc.
    Inventors: Stefan SEEBER, Ulrich GOEPFERT, Andrea OSTERLEHNER, Hubert KETTENBERGER, Wolfgang PAUL
  • Patent number: 10151002
    Abstract: Herein is reported a method for determining methylation of a promoter nucleic acid operably linked to a nucleic acid encoding a polypeptide and thereby determining the long-term productivity of a cell. Also an aspect is a method for selecting a cell for producing a polypeptide by determining the methylation of the promoter nucleic acid operably linked to the structural gene encoding the polypeptide.
    Type: Grant
    Filed: October 9, 2015
    Date of Patent: December 11, 2018
    Assignee: HOFFMANN-LA ROCHE INC.
    Inventors: Ulrich Goepfert, Andrea Osterlehner, Silke Lueckel
  • Publication number: 20160130667
    Abstract: Herein is reported a method for determining methylation of a promoter nucleic acid operably linked to a nucleic acid encoding a polypeptide and thereby determining the long-term productivity of a cell. Also an aspect is a method for selecting a cell for producing a polypeptide by determining the methylation of the promoter nucleic acid operably linked to the structural gene encoding the polypeptide.
    Type: Application
    Filed: October 9, 2015
    Publication date: May 12, 2016
    Inventors: Ulrich Goepfert, Andrea Osterlehner, Silke Simmeth
  • Publication number: 20130034852
    Abstract: Herein is reported a method for determining methylation of a promoter nucleic acid operably linked to a nucleic acid encoding a polypeptide and thereby determining the long-term productivity of a cell. Also an aspect is a method for selecting a cell for producing a polypeptide by determining the methylation of the promoter nucleic acid operably linked to the structural gene encoding the polypeptide.
    Type: Application
    Filed: April 13, 2011
    Publication date: February 7, 2013
    Inventors: Ulrich Goepfert, Andrea Osterlehner, Silke Simmeth
  • Publication number: 20110229903
    Abstract: It is reported herein a method for the determination of the amount of immunoglobulin-encoding mRNA comprising: a) providing a sample, b) performing a polymerase chain reaction for amplifying the light chain with the primers of SEQ ID NO: and 24 and the probe of SEQ ID NO: 33, and/or c) performing a polymerase chain reaction for amplifying the heavy chain with the primers of SEQ ID NO: 19 and 21 and the probe of SEQ ID NO: 40, and d) quantitating with an efficiency of 2.0. The primers with SEQ ID NOs 23 and 24 bind at positions CL 247-266 and CL166-185, respectively, and the probe with SEQ ID NO: 33 binds at 189-212 in human IgG koppa chain. The primer with SEQ ID NO: 19 binds at CH region 2 position 220-237 and the primer with SEQ ID NO: 21 binds at CH region 3 position 114-133. Finally the probe with SEQ ID NO: 40 binds from position 315 in CH2 to position 7 in CH3.
    Type: Application
    Filed: October 21, 2009
    Publication date: September 22, 2011
    Inventors: Ulrich Goepfert, Marlene Jentzsch, Andrea Osterlehner